I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Wennerström, Christina
32
results:
Search for persons
X
Format
Online (32)
Mediatypes
Articles (Online) (14)
OpenAccess-fulltext (18)
Sorted by: Relevance
Sorted by: Year
?
1
Long-term real-world data of ustekinumab in Crohn's disease..:
Bello, Francesca
;
Muhsen, Samer
;
Sabhan, Haider
...
Therapeutic Advances in Gastroenterology. 17 (2024) - p. , 2024
Link:
https://doi.org/10.1177/..
?
2
Drug utilization of biologic therapy in Crohn's disease and..:
Jensen, Kristoffer Jarlov
;
Jensen, Camilla Bjørn
;
Wennerström, Christina
..
Scandinavian Journal of Gastroenterology. 58 (2023) 7 - p. 726-736 , 2023
Link:
https://doi.org/10.1080/..
?
3
Societal costs attributable to Crohn's disease and ulcerati..:
Vadstrup, Kasper
;
Alulis, Sarah
;
Borsi, Andras
...
Scandinavian Journal of Gastroenterology. 55 (2020) 1 - p. 41-46 , 2020
Link:
https://doi.org/10.1080/..
?
4
Objectively assessed disease activity and drug persistence ..:
af Björkesten, Clas-Göran
;
Ilus, Tuire
;
Hallinen, Taru
...
European Journal of Gastroenterology & Hepatology. 32 (2020) 12 - p. 1507-1513 , 2020
Link:
https://doi.org/10.1097/..
?
5
Ustekinumab for Crohn's disease: a nationwide real-life coh..:
Eberl, Anja
;
Hallinen, Taru
;
af Björkesten, Clas-Göran
...
Scandinavian Journal of Gastroenterology. 54 (2019) 6 - p. 718-725 , 2019
Link:
https://doi.org/10.1080/..
?
6
Corrigendum to: Persistence of biologic treatments in psori..:
Geale, Kirk
;
Lindberg, Ingrid
;
Paulsson, Emma C
...
Rheumatology Advances in Practice. 5 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1093/..
?
7
A nationwide real-world study on dynamic ustekinumab dosing..:
Sipponen, Taina
;
af Björkesten, Clas-Göran
;
Hallinen, Taru
...
Scandinavian Journal of Gastroenterology. 56 (2021) 6 - p. 661-670 , 2021
Link:
https://doi.org/10.1080/..
?
8
Societal impact for patients with psoriasis: A nationwide S..:
Häbel, Henrike
;
Wettermark, Björn
;
Hägg, David
...
JAAD International. 3 (2021) - p. 63-75 , 2021
Link:
https://doi.org/10.1016/..
?
9
Persistence of biologic treatments in psoriatic arthritis: ..:
Geale, Kirk
;
Lindberg, Ingrid
;
Paulsson, Emma C
...
Rheumatology Advances in Practice. 4 (2020) 2 - p. , 2020
Link:
https://doi.org/10.1093/..
?
10
Cost Burden of Crohn's Disease and Ulcerative Colitis in th..:
Vadstrup, Kasper
;
Alulis, Sarah
;
Borsi, Andras
...
Inflammatory Bowel Diseases. 26 (2019) 9 - p. 1377-1382 , 2019
Link:
https://doi.org/10.1093/..
?
11
Acid-suppressing therapies and subsite-specific risk of sto..:
Wennerström, E Christina M
;
Simonsen, Jacob
;
Camargo, M Constanza
.
British Journal of Cancer. 116 (2017) 9 - p. 1234-1238 , 2017
Link:
https://doi.org/10.1038/..
?
12
Leukocyte telomere length in relation to the risk of Barret..:
Wennerström, E. Christina M.
;
Risques, Rosa A.
;
Prunkard, Donna
...
Cancer Medicine. 5 (2016) 9 - p. 2657-2665 , 2016
Link:
https://doi.org/10.1002/..
?
13
Long-Term Survival of Individuals Born Small and Large for ..:
Wennerström, E. Christina M.
;
Simonsen, Jacob
;
Melbye, Mads
.
PLOS ONE. 10 (2015) 9 - p. e0138594 , 2015
Link:
https://doi.org/10.1371/..
?
14
Guselkumab Treatment Outcomes and Persistence in a Nationwi..:
MÄLKÖNEN, Tarja
;
NUUTINEN, Pauliina
;
HALLINEN, Taru
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631278/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
15
Guselkumab Treatment Outcomes and Persistence in a Nationwi..:
Mälkönen, Tarja
;
Nuutinen, Pauliina
;
Hallinen, Taru
...
adv00631. , 2022
Link:
https://trepo.tuni.fi/ha..
1-15